TrianglePUBLICATIONS · 26666649
International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer Chemother Pharmacol
- Publication date
- 2016 Feb
- First author
- Casanova M
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Casanova M
- type
- Author
- name
- Özyar E
- type
- Author
- name
- Patte C
- type
- Author
- name
- Orbach D
- type
- Author
- name
- Ferrari A
- type
- Author
- name
- Veyrat-Follet C
- type
- Author
- name
- Errihani H
- type
- Author
- name
- Pan J
- type
- Author
- name
- Zhang L
- type
- Author
- name
- Shen L
- type
- Author
- name
- Grzegorzewski KJ
- type
- Author
- name
- Varan A
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Casanova M
- type
- Author
- name
- Özyar E
- type
- Author
- name
- Patte C
- type
- Author
- name
- Orbach D
- type
- Author
- name
- Ferrari A
- type
- Author
- name
- Veyrat-Follet C
- type
- Author
- name
- Errihani H
- type
- Author
- name
- Pan J
- type
- Author
- name
- Zhang L
- type
- Author
- name
- Shen L
- type
- Author
- name
- Grzegorzewski KJ
- type
- Author
- name
- Varan A
- type
- Author
- bibliography ids
- nci-bib-17887bcc19eb7b4a0113697c
- book metadata
- content sha256
- dc58ae4e4d03885f6e905cd9ba0d20a66635f7bd158bf6612475447e6c9a8969
- document type
- citation
- dois
- 10.1007/s00280-015-2933-2
- electronic publication date
- display
- 2015 Dec 14
- precision
- day
- year
- 2015
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:26666649
- immutable id
- pubmed:26666649@dc58ae4e4d03885f6e905cd9ba0d20a66635f7bd158bf6612475447e6c9a8969
- journal
- abbreviation
- Cancer Chemother Pharmacol
- issn electronic
- 1432-0843
- issn print
- 0344-5704
- issue
- 2
- name
- Cancer chemotherapy and pharmacology
- nlm unique id
- 7806519
- pages
- 289-98
- volume
- 77
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 26666649
- provenance
- batch id
- 948d34b0dea86780a31d
- provider
- NCBI PubMed ESummary
- record sha256
- 9d1e94b3a76d1a7e5822f74fcfbe20734b153b259d15e8345e8dad86c62754fd
- response sha256
- 11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
- retrieved at
- 2026-09-09T23:47:15.495091+00:00
- publication date
- display
- 2016 Feb
- precision
- month
- year
- 2016
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- International randomized phase 2 study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents.
Preserved source evidence · Not medical advice